PF 06281355
Tocris Bioscience, part of Bio-Techne | Catalog # 6004
Selective myeloperoxidase (MPO) inhibitor
Discontinued Product
6004 has been discontinued.
View all Other Oxidase/Oxygenase Compounds products.
Key Product Details
Description
Selective myeloperoxidase (MPO) inhibitor
Product Description
PF 06281355 is a selective myeloperoxidase (MPO) inhibitor (IC50 = 1.5 μM in LPS-stimulated human whole blood). Selective for MPO over a panel of 50 receptors, enzymes, ion channels and transporters, including thyroid peroxidase. Inhibits MPO activity in peritoneal lavage and plasma in a murine peritonitis model. Also reduces lung edema in a murine pulmonary immune complex vasculitis model. Orally bioavailable.Licensing Information
Sold for research purposes under agreement from Pfizer IncProduct Specifications
Molecular Weight
321.35
Formula
C14H15N3O4S
Storage
Store at RT
Purity
≥98% (HPLC)
Chemical Name
6-(2,5-Dimethoxyphenyl)-3,4-dihydro-4-oxo-2-thioxo-1(2H)-pyrimidineacetamide
CAS Number
1435467-38-1
PubChem ID
71568997
InChI Key
LJBUZOGABRDGBR-UHFFFAOYSA-N
SMILES
COC1=CC(C2=CC(NC(N2CC(N)=O)=S)=O)=C(C=C1)OC
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 6.43 | 20 with gentle warming |
Preparing Stock Solutions
for PF 06281355
The following data is based on the product molecular weight 321.35
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.2 mM | 15.56 mL | 77.80 mL | 155.59 mL |
| 1 mM | 3.11 mL | 15.56 mL | 31.12 mL |
| 2 mM | 1.56 mL | 7.78 mL | 15.56 mL |
| 10 mM | 0.31 mL | 1.56 mL | 3.11 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Ruggeri Discovery of 2-(6-(5-chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A highly selective mechanism-based myeloperoxidase inhibitor for the treatment of cardiovascular diseases. J.Med.Chem. 2015 PMID: 26509551
- Zheng PF-1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis. J.Pharmacol.Exp.Ther. 2015 PMID: 25698787
Product Specific Notices for PF 06281355
For research use only
Loading...
Loading...